Generic Index

MELOXICAM ( mell-ox-ih-kam )

Relief of signs and symptoms of osteoarthritis and rheumatoid arthritis. Relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis (JRA) in patients 2 yr of age and older.

NSAIDs may cause an increased risk of serious CV thrombotic events, MI, and stroke that can be fatal. Risk may be increased with duration of use and in patients with CV disease, or risk factors for CV disease. Use lowest effective dose for shortest duration possible. Meloxicam is contraindicated for treatment of perioperative pain in the setting of CABG surgery.

GI risk:

NSAIDs cause an increased risk of serious GI adverse reactions, including bleeding, ulceration, and perforation of the stomach or intestines that can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious GI events.